Aminopyrazine → HCID 71294463, compound
Reaction equation
[CH:1]1([C:6]2[C:7]([O:15][CH2:16][C:17]([F:20])([F:19])[F:18])=[N:8][CH:9]=[C:10]([CH:14]=2)[C:11]([OH:13])=O)[CH2:5][CH2:4][CH2:3][CH2:2]1.[N:21]1[CH:26]=[CH:25][N:24]=[CH:23][C:22]=1[NH2:27]>>[CH:1]1([C:6]2[C:7]([O:15][CH2:16][C:17]([F:20])([F:19])[F:18])=[N:8][CH:9]=[C:10]([CH:14]=2)[C:11]([NH:27][C:22]2[CH:23]=[N:24][CH:25]=[CH:26][N:21]=2)=[O:13])[CH2:2][CH2:3][CH2:4][CH2:5]1Participants
3
Procedure
This compound was prepared following the same procedure as described in Example 11 using 5-cyclopentyl-6-(2,2,2-trifluoro-ethoxy)-nicotinic acid (Example 9c) (50 mg, 0.17 mmol) and 2-pyrazinamine (CAN 5049-61-6, 20 mg, 0.21 mmol) as starting materials; off white solid (15 mg, 23.7%). MS (ESI): 365.2 (M+H)+.
Workup
- customThis compound was prepared
Sources & evidence
- ORD record
- ord-36db240d744d41399f0516d40f2e565c
- Source dataset
- uspto-grants-2014_01
- Patent number
- US08629166B2
Reaction notes
Loading…